| 265 |
What KJPP looks for: guidance from initial editorial screeningWhat KJPP looks for: guidance from initial editorial screening
Chang-Han Lee, Hyun KookChang-Han Lee, Hyun Kook
KMSID: 1516096086 Korean J Physiol Pharmacol. 2026;30(4):265-269. Published online 2026 July 1 DOI: http://dx.doi.org/10.4196/kjpp.26.189 |
|
| 271 |
Sweat glands in action: the role of biological and environmental factors, exercise, and dermatologic conditions in sudomotor functionSweat glands in action: the role of biological and environmental factors, exercise, and dermatologic conditions in sudomotor function
Seunghyun Na, Hye-Jin Lee, Tae-Hwan Park, Jin Kim, Young Hyun Jung, Myeounghoon Cha, Hwa-Young Lee, Hak-Jae Kim, Jeong-Beom LeeSeunghyun Na, Hye-Jin Lee, Tae-Hwan Park, Jin Kim, Young Hyun Jung, Myeounghoon Cha, Hwa-Young Lee, Hak-Jae Kim, Jeong-Beom Lee
KMSID: 1516096087 Korean J Physiol Pharmacol. 2026;30(4):271-287. Published online 2026 July 1 DOI: http://dx.doi.org/10.4196/kjpp.25.192 |
|
| 289 |
Paraoxonase 2 as a target for aging-related diseasesParaoxonase 2 as a target for aging-related diseases
Hyeong Hwan Kim, Ye Jin Kang, Jae Ho Lee, Hyeong Min Lee, Hyung Soon Park, Chang-Hoon NamHyeong Hwan Kim, Ye Jin Kang, Jae Ho Lee, Hyeong Min Lee, Hyung Soon Park, Chang-Hoon Nam
KMSID: 1516096089 Korean J Physiol Pharmacol. 2026;30(4):289-297. Published online 2026 April 29 DOI: http://dx.doi.org/10.4196/kjpp.25.354 |
|
| 299 |
Investigation of the causal effect and molecular signatures of serum hydroxyvitamin D on atherosclerosis: a Mendelian randomization and transcriptomic approachInvestigation of the causal effect and molecular signatures of serum hydroxyvitamin D on atherosclerosis: a Mendelian randomization and transcriptomic approach
Bin Xu, Xinli Liu, Xi Liu, Jiajun Chen, Tingting Cheng, Li ChenBin Xu, Xinli Liu, Xi Liu, Jiajun Chen, Tingting Cheng, Li Chen
KMSID: 1516096088 Korean J Physiol Pharmacol. 2026;30(4):299-312. Published online 2026 January 7 DOI: http://dx.doi.org/10.4196/kjpp.25.278 |
|
| 313 |
Pharmacological inhibition of G protein–coupled receptor kinase 2 (GRK2) by paroxetine attenuates acetaminophen-induced hepatotoxicityPharmacological inhibition of G protein–coupled receptor kinase 2 (GRK2) by paroxetine attenuates acetaminophen-induced hepatotoxicity
Daram Yang, Hee-Won Moon, Jong-Won Kim, Bumseok KimDaram Yang, Hee-Won Moon, Jong-Won Kim, Bumseok Kim
KMSID: 1516096090 Korean J Physiol Pharmacol. 2026;30(4):313-325. Published online 2026 May 18 DOI: http://dx.doi.org/10.4196/kjpp.25.282 |
|
| 327 |
Inhibition of PI3K/Akt/mTOR signaling by curcumin: a novel approach to mitigate synovial fibrosis in knee osteoarthritisInhibition of PI3K/Akt/mTOR signaling by curcumin: a novel approach to mitigate synovial fibrosis in knee osteoarthritis
Chenglong He, Lei Shi, Licheng Zhang, Rui Jiang, Deren Liu, Taiyang Liao, Peng Wu, Jun MaoChenglong He, Lei Shi, Licheng Zhang, Rui Jiang, Deren Liu, Taiyang Liao, Peng Wu, Jun Mao
KMSID: 1516096091 Korean J Physiol Pharmacol. 2026;30(4):327-337. Published online 2026 March 16 DOI: http://dx.doi.org/10.4196/kjpp.25.289 |
|
| 339 |
The influence of exercise duration on inhibiting endoplasmic reticulum stress in ischemic stroke ratsThe influence of exercise duration on inhibiting endoplasmic reticulum stress in ischemic stroke rats
Jin Yoo, Eunjae Jang, Jinsu Hwang, Dohee Kim, Jiyun Choi, Sujeong Jang, Han-Seong Jeong, Daeyeol KimJin Yoo, Eunjae Jang, Jinsu Hwang, Dohee Kim, Jiyun Choi, Sujeong Jang, Han-Seong Jeong, Daeyeol Kim
KMSID: 1516096092 Korean J Physiol Pharmacol. 2026;30(4):339-350. Published online 2026 April 14 DOI: http://dx.doi.org/10.4196/kjpp.25.312 |
|
| 351 |
Astragalus polysaccharide mitigates the airway inflammation in bronchial asthma by regulating Hedgehog/NLRP3/GSDMD pathwayAstragalus polysaccharide mitigates the airway inflammation in bronchial asthma by regulating Hedgehog/NLRP3/GSDMD pathway
Lili Yu, Zibin Liu, Rui Zhang, Jian LaiLili Yu, Zibin Liu, Rui Zhang, Jian Lai
KMSID: 1516096094 Korean J Physiol Pharmacol. 2026;30(4):351-360. Published online 2026 March 16 DOI: http://dx.doi.org/10.4196/kjpp.25.391 |
|
| 361 |
Recombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial–mesenchymal transition suppressionRecombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial–mesenchymal transition suppression
Yanling Wu, Na-Ri Lee, Yu Chuan Liu, Min Sun Kim, Seongwon Hwang, Bumseok Kim, Kwang-Bok Lee, Soo Mi KimYanling Wu, Na-Ri Lee, Yu Chuan Liu, Min Sun Kim, Seongwon Hwang, Bumseok Kim, Kwang-Bok Lee, Soo Mi Kim
KMSID: 1516096093 Korean J Physiol Pharmacol. 2026;30(4):361-375. Published online 2026 July 1 DOI: http://dx.doi.org/10.4196/kjpp.25.369 |
|
